Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.
about
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesUnprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.[HIV-1 diversity: a tool for studying the pandemic].The role of recombination in the emergence of a complex and dynamic HIV epidemic.Genomic Diversity of Human Immunodeficiency Viruses.The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials.Genetic analysis of HIV-1 subtypes in Nairobi, Kenya.HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samplesEvidence for a "Founder Effect" among HIV-infected injection drug users (IDUs) in Pakistan.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AGDevelopment of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtypingInfection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virusPhylogenetic analysis of the p24-p7 region of the human immunodeficiency virus type 1 gag gene to determine subtype distribution among female sex workers in Calcutta, India.On the origin and evolution of the human immunodeficiency virus (HIV).Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in UgandaIdentification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infectionGenetic Characterization of HIV-1 Strains Among the Injecting Drug Users in Nagaland, IndiaField evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire.Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda.Evolutionary Dynamics of Tat in HIV-1 Subtypes B and C.A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission PairsWorldwide molecular epidemiology of HIV.Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.A heteroduplex assay for the rapid detection of dual Human Immunodeficiency Virus Type 1 infectionsInferring viral population structures using heteroduplex mobility and DNA sequence analysesDevelopment, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.Genotyping of enteric adenoviruses by using single-stranded conformation polymorphism analysis and heteroduplex mobility assay.Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations.Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.Use of the heteroduplex mobility assay and cell sorting to select genome sequences of the CCR5 gene in HEK 293T cells edited by transcription activator-like effector nucleases.Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up.Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.HIV-1 seroprevalence in the general population of Salvador, Bahia State, Northeast Brazil.Detection of Human Immunodeficiency Virus Type 1 (HIV-1) A/AE Circulating Recombinant Form (CRF) in India: Possible Implications.HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach.Human immunodeficiency virus type-1 subtypes of infected patients in Espírito Santo, Brazil.
P2860
Q24561905-818176F0-EDD1-47DB-BC7A-27BD9BBDD6A1Q30327384-5213996E-644C-4AAB-A50B-5729089EB665Q30353625-185B4697-D856-432F-BB5A-692240E82A5BQ30387214-9BA42A6B-03A2-4BBF-8304-78F9FF816953Q30390449-B8643782-E8FF-4C4A-9CE9-202ED8692148Q30396176-049C0416-B476-4AF6-976D-5937B96BC6C1Q33368620-93B2CCFD-6F4B-4ADF-BC29-B974CDE6AF72Q33521125-C9C866B4-7063-4850-A73B-B644564E90D5Q33523204-B02C4735-F198-4DB9-BC3A-95FB98AAD360Q33842152-4A7981E5-B3CC-405D-A68C-BB705415C820Q33843999-04E60D60-8C8B-4C0A-9C9A-9254D5B64EB3Q33972312-C58CC586-4F0D-49EC-9C3F-232F459ACAF1Q33972495-93119E2F-3BA5-41E9-AE27-6F683B7285A8Q34120140-5E392C96-7821-48C3-A5B1-F7A68AF9398CQ34143771-9E47021A-9925-4E3B-8D4E-1DB64A00B639Q34276664-328F6140-2ED7-466C-8D84-F02B05BB7331Q34292622-1013C210-F91A-4F15-98F2-7595677C50BDQ34587037-CCA7F680-B006-4023-A617-82F9CA8CDCD1Q34781890-C96D3AC3-A255-4653-BAC3-8FA3E507AB23Q35020053-3C41DBEE-A4DB-4069-9E33-D8FEE20AECC5Q35121031-68DDB9C9-082B-4676-B504-AD8E5238605EQ35156162-BD050BB4-B4FF-4AE3-AE2A-63974155644FQ35551514-D1347B68-B23E-47E1-B4C3-E60857AB3083Q35667483-84DF4C3E-AE80-4A54-9329-E176E526712EQ36419536-01815016-0AAB-42F2-B99B-EE7E0109AEAFQ36438805-73BEADFF-5BC5-4F17-BA2F-524810384439Q36973809-71F293B3-03AB-40DA-88E7-4E3B5EA6B78AQ37173744-EC1934AB-5A1B-455B-80D5-91ECFF93E751Q37302765-2056A273-6267-468D-BC97-076E0AAAC136Q37419768-3C13CB47-5256-4829-BE2D-0EB99EA16E5CQ37420710-030435AB-EBE0-4F97-91DC-7677748BAED7Q37567877-E23DAE9A-636B-46A7-AB36-3E037E771FF0Q37744047-B9B473D4-A2F5-4F5B-8D8A-8DF03E49CA04Q38334508-E40A1D41-A68A-4AE4-AE92-AF81522B1D58Q38867914-3E46E189-338A-47D3-8D2E-D66FD2E991F3Q39626666-573748BD-BF00-4A0B-A8D8-E12E924769F8Q39779506-3C7295CF-FCF6-447C-ABAF-EB95EBF170CFQ41162950-2372433B-1FD8-414D-A994-B2D719203AD0Q41918265-B5F8AD4C-DB3C-4A04-A983-DFA4741B8D8FQ45407359-6FF031B3-B55E-4DD2-807C-F2DFB327F2CF
P2860
Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Simplified strategy for detect ...... V Epidemics in African Cities.
@ast
Simplified strategy for detect ...... V Epidemics in African Cities.
@en
type
label
Simplified strategy for detect ...... V Epidemics in African Cities.
@ast
Simplified strategy for detect ...... V Epidemics in African Cities.
@en
prefLabel
Simplified strategy for detect ...... V Epidemics in African Cities.
@ast
Simplified strategy for detect ...... V Epidemics in African Cities.
@en
P2093
P2860
P1433
P1476
Simplified strategy for detect ...... V Epidemics in African Cities.
@en
P2093
F E McCutchan
G Van der Auwera
G van Der Groen
J Goudsmit
K De Witte
K Vereecken
P2860
P304
P356
10.1128/JVI.74.1.363-370.2000
P577
2000-01-01T00:00:00Z